Compound Lophatherum gracile tablets Ⅱ
Function and Efficacy
Animal experiments have shown that this product has a significant antihypertensive effect on renal hypertension; it can counteract arrhythmias caused by aconitine, calcium chloride and coronary artery ligation, and its antiarrhythmic mechanism may be related to the effect on calcium ion influx.
Ingredients
This product is a compound preparation, and its components are: each tablet contains 43.7 mg of dry powder of Apocynum venetum decoction, 28.5 mg of dry powder of Chrysanthemum indica decoction, 30.7 mg of dry powder of Stephania tetrandra decoction, 15 mg of magnesium trisilicate, 1.3 mg of guanidine sulfate, 1.6 mg of hydralazine sulfate, 1.6 mg of hydrochlorothiazide, 1.05 mg of promethazine hydrochloride, 0.5 g of vitamin B1, 0.5 g of vitamin B6, and 0.25 mg of calcium pantothenate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Magnesium trisilicateIngredients |
It has a significant antihypertensive effect on renal hypertension; it can counteract arrhythmias caused by aconitine, calcium chloride and coronary artery ligation. Its antiarrhythmic mechanism may be related to affecting calcium ion influx. More |
14987-04-3 | 11 | |
| GUANOXAN SULFATEIngredients |
It has a significant antihypertensive effect on renal hypertension; it can counteract arrhythmias caused by aconitine, calcium chloride and coronary artery ligation. Its antiarrhythmic mechanism may be related to affecting calcium ion influx. More |
5714-04-5 | 1 | |
| OphthazinIngredients |
It has a significant antihypertensive effect on renal hypertension; it can counteract arrhythmias caused by aconitine, calcium chloride and coronary artery ligation. Its antiarrhythmic mechanism may be related to affecting calcium ion influx. More |
484-23-1 | 0 | |
| HydrochlorothiazideIngredients |
It has a significant antihypertensive effect on renal hypertension; it can counteract arrhythmias caused by aconitine, calcium chloride and coronary artery ligation. Its antiarrhythmic mechanism may be related to affecting calcium ion influx. More |
58-93-5 | 54 | |
| Promethazine hydrochlorideIngredients |
It has a significant antihypertensive effect on renal hypertension; it can counteract arrhythmias caused by aconitine, calcium chloride and coronary artery ligation. Its antiarrhythmic mechanism may be related to affecting calcium ion influx. More |
58-33-3 | 29 | |
| Thiamine chlorideIngredients |
It has a significant antihypertensive effect on renal hypertension; it can counteract arrhythmias caused by aconitine, calcium chloride and coronary artery ligation. Its antiarrhythmic mechanism may be related to affecting calcium ion influx. More |
59-43-8 | 9 | |
| Vitamin B6Ingredients |
It has a significant antihypertensive effect on renal hypertension; it can counteract arrhythmias caused by aconitine, calcium chloride and coronary artery ligation. Its antiarrhythmic mechanism may be related to affecting calcium ion influx. More |
8059-24-3 | 13 | |
| Calcium D-PantothenateIngredients |
It has a significant antihypertensive effect on renal hypertension; it can counteract arrhythmias caused by aconitine, calcium chloride and coronary artery ligation. Its antiarrhythmic mechanism may be related to affecting calcium ion influx. More |
137-08-6 | 8 |
Appearance
This product is a sugar-coated tablet.
Indication
No data yet
Usage and Dosage
Oral administration: 2 tablets at a time, 3 times a day. Maintenance dose: 2 tablets a day.
Adverse Reactions
No adverse reactions have been reported.
Precautions
It is contraindicated for those who are allergic to this product.
Special Population Medication
Precautions for children: Reduce the dosage or follow the doctor's advice. Precautions for pregnancy and lactation: This product is not the first choice for pregnant and lactating women with hypertension. Precautions for the elderly: This product has not been tested and there is no reliable reference.
Drug Interactions
Not yet clear.
Storage
Keep sealed.
Packaging Specification
Compound
Validity Period
24 months
Manufacturer
Jilin Xianfeng Technical Pharmaceutical Co., Ltd.
-
Founded in:
2003-01-14 -
Address:
No. 9, Xianfeng Street, Nong'an County -
Tax NO.:
9122012274303157XG -
Registered Funds:
35 million yuan -
Website:
-
Email: